LP002 / Lepu Med  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
LP002 / Lepu Med
NCT04740021: Study of LP002 in Combination With Chemotherapy for Patients With Extensive Stage Small Cell Lung Cancer

Recruiting
2
46
RoW
LP002, Carboplatin, Etoposide
Taizhou HoudeAoke Biomedical Co., Ltd.
Small-cell Lung Cancer
02/22
08/22
NCT04600947: Study of LP002 for the Treatment of Patients With Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma

Not yet recruiting
2
69
RoW
LP002
Taizhou HoudeAoke Biomedical Co., Ltd.
Primary Mediastinal Large B-Cell Lymphoma (PMBCL)
05/22
05/23

Download Options